AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Purchases 88,000 Shares of Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett purchased 88,000 shares of the company’s stock in a transaction dated Wednesday, March 11th. The shares were bought at an average cost of $2.15 per share, for a total transaction of $189,200.00. Following the acquisition, the insider owned 6,486,211 shares in the company, valued at approximately $13,945,353.65. The trade was a 1.38% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Friday, March 6th, Jorey Chernett purchased 45,600 shares of AirSculpt Technologies stock. The stock was bought at an average price of $2.00 per share, with a total value of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The shares were bought at an average cost of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett acquired 80,000 shares of AirSculpt Technologies stock. The shares were bought at an average price of $1.71 per share, for a total transaction of $136,800.00.

AirSculpt Technologies Stock Performance

AIRS stock traded down $0.03 on Thursday, hitting $2.23. The company had a trading volume of 129,648 shares, compared to its average volume of 1,174,174. AirSculpt Technologies, Inc. has a 12-month low of $1.51 and a 12-month high of $12.00. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.63. The stock’s 50-day simple moving average is $2.21 and its 200 day simple moving average is $4.76. The stock has a market cap of $139.24 million, a price-to-earnings ratio of -7.37 and a beta of 2.75.

Institutional Trading of AirSculpt Technologies

Several hedge funds have recently bought and sold shares of AIRS. Vesey Street Capital Partners L.L.C. raised its stake in shares of AirSculpt Technologies by 3.4% in the second quarter. Vesey Street Capital Partners L.L.C. now owns 30,324,180 shares of the company’s stock worth $146,466,000 after buying an additional 1,000,000 shares during the period. Balyasny Asset Management L.P. grew its stake in shares of AirSculpt Technologies by 128.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after acquiring an additional 626,309 shares during the period. Renaissance Technologies LLC purchased a new stake in AirSculpt Technologies in the 4th quarter worth approximately $1,991,000. Vanguard Group Inc. increased its holdings in AirSculpt Technologies by 10.8% in the 3rd quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock worth $6,276,000 after acquiring an additional 76,291 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in AirSculpt Technologies by 4.6% during the 4th quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock worth $798,000 after acquiring an additional 17,889 shares during the period. Institutional investors own 91.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $6.00.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.